[go: up one dir, main page]

NO20041671L - Anthelmintic composition - Google Patents

Anthelmintic composition

Info

Publication number
NO20041671L
NO20041671L NO20041671A NO20041671A NO20041671L NO 20041671 L NO20041671 L NO 20041671L NO 20041671 A NO20041671 A NO 20041671A NO 20041671 A NO20041671 A NO 20041671A NO 20041671 L NO20041671 L NO 20041671L
Authority
NO
Norway
Prior art keywords
anthelmintic composition
parts selected
anthelmintic
composition
praziquan
Prior art date
Application number
NO20041671A
Other languages
English (en)
Norwegian (no)
Inventor
Toshimitsu Toyama
Akio Saito
Yoko Sugiyama
Toshihiko Nanba
Original Assignee
Novartis Animal Health Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Animal Health Kk filed Critical Novartis Animal Health Kk
Publication of NO20041671L publication Critical patent/NO20041671L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20041671A 2001-10-25 2004-04-22 Anthelmintic composition NO20041671L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001327198 2001-10-25
PCT/JP2002/011067 WO2003034825A1 (fr) 2001-10-25 2002-10-24 Composition anthelmintique

Publications (1)

Publication Number Publication Date
NO20041671L true NO20041671L (no) 2004-07-16

Family

ID=19143465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041671A NO20041671L (no) 2001-10-25 2004-04-22 Anthelmintic composition

Country Status (17)

Country Link
US (1) US20040254125A1 (fr)
EP (1) EP1449435A4 (fr)
KR (1) KR20040047962A (fr)
CN (1) CN1592577A (fr)
AU (1) AU2002338201B2 (fr)
BR (1) BR0213550A (fr)
CA (1) CA2464403A1 (fr)
CO (1) CO5580745A2 (fr)
HU (1) HUP0401677A2 (fr)
IL (1) IL161560A0 (fr)
MX (1) MXPA04003854A (fr)
NO (1) NO20041671L (fr)
NZ (1) NZ532977A (fr)
PL (1) PL370227A1 (fr)
RU (1) RU2004115744A (fr)
WO (1) WO2003034825A1 (fr)
ZA (1) ZA200403323B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192319A1 (en) * 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US20090281175A1 (en) * 2006-09-28 2009-11-12 Galderma S.A. Avermectin compounds and treatment of dermatological disorders in humans therewith
TW200924647A (en) 2007-08-30 2009-06-16 Schering Plough Ltd Local topical administration formulations containing fipronil
GB2457734A (en) * 2008-02-25 2009-08-26 Norbrook Lab Ltd Topical phenyl pyrazole insecticide composition
BRPI0802255A2 (pt) * 2008-06-17 2010-03-16 Sespo Ind E Com Ltda composição de uso tópico para controle de ectoparasitos em cães e gatos
EP2416663A2 (fr) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Formulation parasiticide
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
RU2024527C1 (ru) * 1986-03-25 1994-12-15 Санкио Компани Лимитед Способ получения макролидных соединений
US4831016A (en) * 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
US5428034A (en) * 1988-09-02 1995-06-27 Sankyo Co., Ltd. Milbemycin derivatives, their preparation and their use
KR0171426B1 (ko) * 1991-12-18 1999-02-01 가와무라 요시부미 13-(치환 티오) 아세톡시밀베마이신 유도체, 그의 제조방법 및 농화학적 용도
AU694016B2 (en) 1995-05-10 1998-07-09 Virbac (Australia) Pty Limited Canine anthelmintic preparation
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
CA2186650A1 (fr) 1995-09-29 1997-03-30 Kazuo Sato Derives de substitution en 13 de milbemycin-5-oxime; preparation et utilisation contre les insectes et d'autres parasites
US6165987A (en) * 1996-07-30 2000-12-26 Harvey; Colin Manson Anthelmintic formulations
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
JP3314148B2 (ja) * 1996-09-24 2002-08-12 三共株式会社 樹幹注入剤
NZ514026A (en) * 1999-02-09 2001-09-28 Kitasato Inst A vermectin derivatives
GB9916052D0 (en) 1999-07-08 1999-09-08 Pfizer Ltd Anthelmintic compositions
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
NZ522247A (en) * 2000-04-27 2004-07-30 Sankyo Lifetech Company Ltd 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests

Also Published As

Publication number Publication date
RU2004115744A (ru) 2005-04-10
IL161560A0 (en) 2004-09-27
WO2003034825A1 (fr) 2003-05-01
CN1592577A (zh) 2005-03-09
HUP0401677A2 (hu) 2004-12-28
MXPA04003854A (es) 2005-02-17
EP1449435A1 (fr) 2004-08-25
PL370227A1 (en) 2005-05-16
KR20040047962A (ko) 2004-06-05
CA2464403A1 (fr) 2003-05-01
BR0213550A (pt) 2004-08-31
NZ532977A (en) 2007-01-26
ZA200403323B (en) 2004-11-08
EP1449435A4 (fr) 2005-01-05
CO5580745A2 (es) 2005-11-30
AU2002338201B2 (en) 2007-06-28
US20040254125A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
DK1385515T3 (da) Spiropyrazole forbindelser
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
NO20062267L (no) Hepatitt C virus inhibitorer
DE60212867D1 (de) Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
NO20062339L (no) Hepatitt C virus-inhibitoerer
NO20044807L (no) Heratitt C virus inhibitorer
DK1263722T3 (da) Farmaceutiske sammensætninger, som indeholder azetidinderivat, nye azetidinderivater og fremstilling deraf
ATE433447T1 (de) Pyrimiidinverbindungen
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
HRP20030383B1 (hr) Laktamski spoj
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
HRP20090195T1 (hr) Inhibitori mitotičkih kinezina
NO20024614L (no) N-heterosykliske derivater som NOS-hemmere
NO20034661L (no) Nociceptin-analoger
ATE338461T1 (de) Pyrazolpyrimidinfungizide
NO20080801L (no) Aerosolformulering for inhalering av beta-agonister
NO20040881L (no) Orale antidiabetes midler.
ES2243579T3 (es) Derivados de pirazolopirideno.
SE0004245D0 (sv) Novel compounds and their use
NO20044767L (no) Farmasoytisk formulering med modifisert frigjoring
NO20054787L (no) Indenderivater som farmasotiske midler
DE60217335D1 (de) Biozid wirkendes reinigungsmittel
NO20041671L (no) Anthelmintic composition
DK1408966T3 (da) Synergistiske farmaceutiske kombinationer til forebyggelse eller behandling af diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application